Piramal Pharma reports consolidated net loss of Rs 88.64 crore in Q1

27 Jul 2024 Evaluate

Piramal Pharma has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported net profit at Rs 85.27 crore for Q1FY25 as compared to net loss of Rs 33.36 crore for the same quarter in the previous year. Total income of the company increased by 25.98% at Rs 1,099.96 crore for Q1FY25 as compared to Rs 873.11 crore for the corresponding quarter previous year. 

On consolidated basis, the company has reported net loss at Rs 88.64 crore for the quarter ended June 30, 2024 as compared to net loss of Rs 98.58 crore for the same quarter in the previous year. However, total income of the company increased by 10.27% at Rs 1,970.68 crore for Q1FY25 as compared to Rs 1,787.16 crore for the corresponding quarter previous year.


Piramal Pharma Share Price

252.60 -9.00 (-3.44%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.